Crossmark

Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria

Crossref DOI link: https://doi.org/10.1007/s15010-018-1253-y

Published Online: 2018-11-17

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hof, Herbert https://orcid.org/0000-0002-6366-2517
Juretschke, C.
License Information

Text and Data Mining valid from 2018-11-17
More Information

Article History

Received: 3 October 2018

Accepted: 13 November 2018

First Online: 17 November 2018

Compliance with ethical standards

:

: The authors declare that they do not have any conflicts of interest.